Views Article – Sharenet Wealth

Europe, News

AstraZeneca resumes COVID-19 vaccine trials in South Africa, health dept says

(Adding details)

By Mfuneko Toyana

JOHANNESBURG, Sept 15 (Reuters) – AstraZeneca has resumed COVID-19 vaccine trials in South Africa, more than a week after tests were paused due to serious side effects in a participant in Britain, an official at the country’s Department of Health told Reuters on Tuesday.

The move, confirmed to Reuters by director of affordable medicines in the health department, Khadija Jamaloodien, comes after the British drugmaker on Saturday got the go-ahead to restart trials in the UK, prompting Brazil to follow suit.

Tests remain on hold in the United States pending an investigation and the Serum Institute of India said it would restart its trials once it had permission from the Drugs Controller General of India. (Reporting by Mfuneko Toyana Writing by Josephine Mason in London; editing by David Evans)

© 2019 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.